Respiratory syncytial virus mRNA vaccine(Walvax Biotech)

呼吸道合胞病毒mRNA疫苗（云南沃森生物）

Report date: 2025/11/04 13:38:36

Base Information

Drug NameRespiratory syncytial virus mRNA vaccine(Walvax Biotech)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesWalvax Biotechnology Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesWalvax Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsRespiratory Syncytial Virus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A